Axel Schumacher

Axel Schumacher (born June 14, 1969), is a German epigenetics researcher. He invented the first microarray technologies for epigenetic biomarker discovery, developed the ‘epigenetic theory of aging’ with his research leading to the worldwide first proof of whole genome epigenetic abnormalities in Alzheimer's disease.

Alongside his work as a scientist he is a published author, a futurologist and as of July 2017, CEO and co-founder of the HLTH.network. Provided by Wikipedia